Paper39690384
Comparison of Intratumoral and Peritumoral Deep Learning, Radiomics, and Fusion Models for Predicting KRAS Gene Mutations in Rectal Cancer Based on Endorectal Ultrasound Imaging.
Gan Y and 7 others. Ann Surg Oncol, 2025. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Comparison of Intratumoral and Peritumoral Deep Learning, Radiomics, and Fusion Models for Predicting KRAS Gene Mutations in Rectal Cancer Based on Endorectal Ultrasound Imaging. Papers, record 39690384. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39690384
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparison of Intratumoral and Peritumoral Deep Learning, Radiomics, and Fusion Models for Predicting KRAS Gene Mutations in Rectal Cancer Based on Endorectal Ultrasound Imaging.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Deep Learning | Major topic |
| Rectal Neoplasms | Major topic |
| Proto-Oncogene Proteins p21(ras) | Major topic |
| Mutation | Major topic |
| Endosonography | Major topic |
| Humans | |
| Male | |
| Female | |
| Middle Aged | |
| Prognosis | |
| Follow-Up Studies | |
| Aged | |
| ROC Curve | |
| Radiomics |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33591350 | Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. | JAMA | 2021 | https://conductscience.org/library/papers/33591350 | PubMed |
| 2 | 32203400 | The multidisciplinary management of rectal cancer. | Nat Rev Gastroenterol Hepatol | 2020 | https://conductscience.org/library/papers/32203400 | PubMed |
| 3 | 33216491 | The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal Cancer. | Dis Colon Rectum | 2020 | https://conductscience.org/library/papers/33216491 | PubMed |
| 4 | 29450468 | Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial. | JAMA Oncol | 2018 | https://conductscience.org/library/papers/29450468 | PubMed |
| 5 | 30422156 | Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer: The UNICANCER PRODIGE18 Randomized Clinical Trial. | JAMA Oncol | 2019 | https://conductscience.org/library/papers/30422156 | PubMed |
| 6 | 34742312 | Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer. | Mol Cancer | 2021 | https://conductscience.org/library/papers/34742312 | PubMed |
| 7 | 31972237 | Precision Therapy in RAS Mutant Colorectal Cancer. | Gastroenterology | 2020 | https://conductscience.org/library/papers/31972237 | PubMed |
| 8 | 34919826 | KRASG12C inhibition in colorectal cancer. | Lancet Oncol | 2022 | https://conductscience.org/library/papers/34919826 | PubMed |
| 9 | 35484252 | The prognostic value of KRAS mutation in locally advanced rectal cancer. | Int J Colorectal Dis | 2022 | https://conductscience.org/library/papers/35484252 | PubMed |
| 10 | 35845506 | Prognostic impact of high-risk factors and KRAS mutation in patients with stage II deficient mismatch repair colon cancer: a retrospective cohort study. | Ann Transl Med | 2022 | https://conductscience.org/library/papers/35845506 | PubMed |
| 11 | 36980565 | Colorectal Cancer Liver Metastases: Genomics and Biomarkers with Focus on Local Therapies. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36980565 | PubMed |
| 12 | 29335867 | Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer? | Eur Radiol | 2018 | https://conductscience.org/library/papers/29335867 | PubMed |
| 13 | 29362371 | KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer. | Sci Rep | 2018 | https://conductscience.org/library/papers/29362371 | PubMed |
| 14 | 35048135 | The application of radiomics in predicting gene mutations in cancer. | Eur Radiol | 2022 | https://conductscience.org/library/papers/35048135 | PubMed |
| 15 | 34824449 | Machine learning-based pathomics signature could act as a novel prognostic marker for patients with clear cell renal cell carcinoma. | Br J Cancer | 2022 | https://conductscience.org/library/papers/34824449 | PubMed |
| 16 | 31147560 | Machine-learning Approach for the Development of a Novel Predictive Model for the Diagnosis of Hepatocellular Carcinoma. | Sci Rep | 2019 | https://conductscience.org/library/papers/31147560 | PubMed |
| 17 | 30691352 | Machine Learning to Predict Delays in Adjuvant Radiation following Surgery for Head and Neck Cancer. | Otolaryngol Head Neck Surg | 2019 | https://conductscience.org/library/papers/30691352 | PubMed |
| 18 | 37150712 | Machine learning versus logistic regression for the prediction of complications after pancreatoduodenectomy. | Surgery | 2023 | https://conductscience.org/library/papers/37150712 | PubMed |
| 19 | 38657439 | Hematologic cancer diagnosis and classification using machine and deep learning: State-of-the-art techniques and emerging research directives. | Artif Intell Med | 2024 | https://conductscience.org/library/papers/38657439 | PubMed |
| 20 | 31982342 | Deep Learning Features Improve the Performance of a Radiomics Signature for Predicting KRAS Status in Patients with Colorectal Cancer. | Acad Radiol | 2020 | https://conductscience.org/library/papers/31982342 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42587550 | Multi-Modal Ultrasound-Based Prognostic Model for Diffuse Large B-Cell Lymphoma with Predominantly Superficial Lymph Node Involvement. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42587550 | PubMed |
| 42433515 | Comparing deep-learning, radiomics, and fusion models for parathyroid tumor classification using ultrasound: a multicenter retrospective study. | Quant Imaging Med Surg | 2026 | https://conductscience.org/library/papers/42433515 | PubMed |
| 41821894 | Identification of KRAS mutation in rectal cancer based on a 2.5D deep learning model. | Front Oncol | 2026 | https://conductscience.org/library/papers/41821894 | PubMed |
| 41813761 | Innovative fusion models: elevating preoperative gross ETE prediction in thyroid cancer patients. | Sci Rep | 2026 | https://conductscience.org/library/papers/41813761 | PubMed |
| 41583907 | Radiogenomics: Current Understandings and Future Perspectives. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/41583907 | PubMed |
| 41430161 | Deep learning-based MRI model for predicting P53-mutated hepatocellular carcinoma. | BMC Med Imaging | 2025 | https://conductscience.org/library/papers/41430161 | PubMed |
| 40969275 | Key parameters in intratumoral-peritumoral region fusion models: optimizing deep learning radiomics for breast cancer diagnosis. | Front Oncol | 2025 | https://conductscience.org/library/papers/40969275 | PubMed |
| 40909964 | Research progress on predicting KRAS gene mutations in colorectal cancer by combining radiomics and multimodal medical imaging. | Front Oncol | 2025 | https://conductscience.org/library/papers/40909964 | PubMed |
| 40837773 | Correlation between baseline magnetic resonance imaging features and serum carcinoembryonic antigen levels in patients with primary rectal cancer. | World J Gastrointest Oncol | 2025 | https://conductscience.org/library/papers/40837773 | PubMed |
| 39753796 | ASO Author Reflections: Preoperative Evaluation of KRAS Gene Mutations in Rectal Cancer. | Ann Surg Oncol | 2025 | https://conductscience.org/library/papers/39753796 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| KRAS | 3845 | PubTator's text mining | https://conductscience.org/library/genes/3845 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39690384
GET https://conductscience.org/api/papers/v1/39690384/references?page=2